Reduction in Drug-Related Overdoses Associated With Unemployment Insurance

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, Aug. 12, 2024 -- Unemployment insurance (UI), operationalized as the weekly benefit allowance (WBA) replacement rate, is associated with a lower risk for drug-related overdose, according to a study published in the August issue of the International Journal of Drug Policy.

Silvia S. Martins, M.D., Ph.D., from the Columbia University Mailman School of Public Health in New York City, and colleagues used data from the pooled 2014 to 2020 Detailed Restricted Mortality files for all counties from the U.S. Centers for Disease Control and Prevention to examine whether UI, operationalized as the WBA replacement rate, is negatively associated with drug-related overdoses. The association between the WBA replacement rate and each county-level age-adjusted mortality outcome was modeled during 2014 to 2020: pre-COVID-19 (2014 to 2018) and COVID-19 (2019 to 2020).

The researchers found that across the entire study period, a more robust WBA replacement rate was associated with a lower risk for any drug, opioid, or stimulant overdose (risk differences, −0.06, −0.04, and −0.03, respectively). In the pre-COVID-19 period, a more robust WBA replacement rate was associated with fewer fatal drug, opioid, and stimulant overdoses, while associations were seen for any fatal drug and stimulant overdoses in the COVID-19 period.

"Although additional research is needed to further interrogate these findings, together the results support the premise that higher WBA replacements rates could serve to buffer some of the adverse consequences of job loss on drug overdose mortality risk at the population level," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-08-13 01:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords